Lifevantage (LFVN) to Release Earnings on Thursday

Lifevantage (NASDAQ:LFVN) is projected to post its Q4 2026 results after the market closes on Thursday, August 27th. Analysts expect the company to announce earnings of $0.15 per share and revenue of $44.00 million for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning results page for the latest details on the call scheduled for Thursday, August 27, 2026 at 4:30 PM ET.

Lifevantage Trading Up 2.2%

Shares of Lifevantage stock opened at $6.84 on Tuesday. The company’s 50-day moving average price is $6.39 and its two-hundred day moving average price is $5.80. Lifevantage has a 52 week low of $3.90 and a 52 week high of $14.28. The stock has a market cap of $86.32 million, a PE ratio of 15.20 and a beta of 0.72.

Lifevantage Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.20 annualized dividend and a dividend yield of 2.9%. Lifevantage’s dividend payout ratio (DPR) is 44.44%.

Institutional Investors Weigh In On Lifevantage

Several hedge funds have recently modified their holdings of the stock. Cubist Systematic Strategies LLC acquired a new stake in shares of Lifevantage during the first quarter valued at approximately $97,000. Jones Financial Companies Lllp boosted its stake in Lifevantage by 14,484.0% in the 1st quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company’s stock worth $425,000 after purchasing an additional 28,968 shares during the period. Goldman Sachs Group Inc. boosted its stake in Lifevantage by 24.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company’s stock worth $649,000 after purchasing an additional 8,762 shares during the period. Jane Street Group LLC grew its position in Lifevantage by 5.4% during the 1st quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock worth $533,000 after purchasing an additional 1,877 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares in the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on LFVN. Lake Street Capital downgraded shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price on the stock. in a report on Thursday, May 7th. Weiss Ratings raised shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, Lifevantage currently has an average rating of “Hold” and a consensus price target of $5.00.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.